Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Joe S Mendez"'
Autor:
Ryan D Kraus, Christopher R Weil, Fan-Chi Frances Su, Donald M Cannon, Lindsay M Burt, Joe S Mendez
Publikováno v:
Neurooncol Pract
Background A post-operative MRI (MRIpost-op) performed within 72 h is routinely used for radiation treatment planning in glioblastoma (GBM) patients, with radiotherapy starting about 4–6 weeks after surgery. Some patients undergo an additional pre-
Autor:
Calixto-Hope G Lucas, Christian J Davidson, Mouied Alashari, Angelica R Putnam, Nicholas S Whipple, Carol S Bruggers, Joe S Mendez, Samuel H Cheshier, Jeffrey B Walker, Biswarathan Ramani, Cathryn R Cadwell, Daniel V Sullivan, Rufei Lu, Kanish Mirchia, Jessica Van Ziffle, Patrick Devine, Ezequiel Goldschmidt, Shawn L Hervey-Jumper, Nalin Gupta, Nancy Ann Oberheim Bush, David R Raleigh, Andrew Bollen, Tarik Tihan, Melike Pekmezci, David A Solomon, Joanna J Phillips, Arie Perry
Publikováno v:
J Neuropathol Exp Neurol
Journal of neuropathology and experimental neurology, vol 81, iss 8
Journal of neuropathology and experimental neurology, vol 81, iss 8
Composite pleomorphic xanthoastrocytoma-ganglioglioma (PXA-GG) is an extremely rare central nervous system neoplasm with 2 distinct but intermingled components. Whether this tumor represents a “collision tumor” of separate neoplasms or a monoclon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ad0b321c7b4d9dbc6bc0a4c5593793e
https://europepmc.org/articles/PMC9297094/
https://europepmc.org/articles/PMC9297094/
Publikováno v:
Journal of neuro-oncology. 159(2)
A BSTRACT: PURPOSE: Optimal treatment for primary central nervous system lymphoma (PCNSL) comprises polychemotherapy induction with high-dose methotrexate followed by consolidation therapy, but there is no standard treatment regimen because of a lack
Autor:
Lindsay M. Burt, Nicholas S Whipple, Matthew M. Poppe, M.W. Parsons, Donald M. Cannon, Joe S Mendez
Publikováno v:
Journal of Neuro-Oncology. 151:93-101
The aim of this study was to understand the use of chemotherapy (CMT) and radiotherapy (RT) in pilocytic astrocytoma (PA) and their impact on overall survival (OS). Data from the National Cancer Database (NCDB) for patients with non-metastatic WHO gr
Autor:
Ekin Güney, Calixto-Hope G. Lucas, Zhongxia Qi, Jingwei Yu, Ruth Zhang, Robert S. Ohgami, James L. Rubenstein, Daniel R. Boué, Kristian Schafernak, Gerald B. Wertheim, Sonika Dahiya, Lisa Giulino-Roth, Andishe Attarbaschi, Matthew J. Barth, Shalin Kothari, Oussama Abla, Adam L. Cohen, Joe S. Mendez, Andrew Bollen, Arie Perry, Tarik Tihan, Melike Pekmezci, David A. Solomon, Kwun Wah Wen
Publikováno v:
Blood advances. 6(10)
Autor:
Matthew W, Parsons, Nicholas S, Whipple, Matthew M, Poppe, Joe S, Mendez, Donald M, Cannon, Lindsay M, Burt
Publikováno v:
Journal of neuro-oncology. 151(2)
The aim of this study was to understand the use of chemotherapy (CMT) and radiotherapy (RT) in pilocytic astrocytoma (PA) and their impact on overall survival (OS).Data from the National Cancer Database (NCDB) for patients with non-metastatic WHO gra
Autor:
Joe S. Mendez, Lisa M. DeAngelis
Publikováno v:
Neurologic Clinics. 36:579-598
Neurologic complications of cancer may involve both the central nervous system (CNS) and peripheral nervous system (PNS) manifesting as brain, leptomeningeal, intramedullary, intradural, epidural, plexus, and skull base metastases. Excluding brain in
Autor:
Christian Grommes, Joe S. Mendez
Publikováno v:
American Society of Clinical Oncology Educational Book. :604-615
Primary central nervous system lymphoma (PCNSL) is a rare form of extranodal non-Hodgkin lymphoma that is typically confined to the brain, eyes, and cerebrospinal fluid (CSF) without evidence of systemic spread. PCNSL is an uncommon tumor, and only f
Autor:
Quinn T. Ostrom, Carol Kruchko, Jill S. Barnholtz-Sloan, Haley Gittleman, Christian Grommes, Joe S. Mendez, Lisa M. DeAngelis
Publikováno v:
Neuro-Oncology. 20:687-694
BACKGROUND: There has been significant improvement in treatment outcomes of primary central nervous system lymphoma (PCNSL) at specialized centers over the past several decades; however, it is unclear if these changes have translated to benefits in t
Publikováno v:
Journal of Clinical Oncology. 38:e14544-e14544
e14544 Background: Treatment for Primary Central Nervous System Lymphoma (PCNSL) includes induction therapy consisting of polychemotherapy including high-dose methotrexate followed by consolidation therapy. There are various induction and consolidati